Strategic Acquisition The recent acquisition by Aterian Investment Partners positions CPL as part of a larger portfolio of pharmaceutical service providers, opening opportunities for cross-selling advanced development, manufacturing, and packaging solutions to sister companies within the investment group's network.

Facility Modernization CPL has invested over $20 million in new manufacturing and packaging equipment, including explosion-proof capabilities, signaling a commitment to expanding capacity and improving compliance, which can be leveraged to offer enhanced scaling and technology upgrades to clients seeking reliable manufacturing upgrades.

Regulatory Compliance With facilities registered with both FDA and Health Canada and routine audits, CPL emphasizes high regulatory standards, making it an attractive partner for companies seeking compliant manufacturing solutions in North America, especially in non-sterile liquid and semi-solid segments.

Market Focus CPL’s focus on non-sterile liquid and semi-solid pharmaceutical and OTC products offers targeted sales opportunities with brands looking for reliable, regulatory-compliant CDMO services to accelerate their product development and commercialization efforts.

Technological Capabilities Utilizing advanced systems like TrackWise and SAP for quality and maintenance management indicates a sophisticated operational infrastructure, presenting sales potential for integrated software solutions that can optimize manufacturing workflows and compliance tracking.